Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct;9(5):265-72.
doi: 10.1016/j.surge.2010.12.005. Epub 2011 Feb 3.

The Management of Solitary Colorectal Liver Metastases

Affiliations
Review

The Management of Solitary Colorectal Liver Metastases

Antoine Brouquet et al. Surgeon. .

Abstract

Surgical resection of solitary colorectal liver metastases is associated with long-term survival. Radiofrequency ablation used as the primary treatment option of solitary resectable colorectal liver metastases is associated with an increased risk of local recurrence that generally leads to worse survival compared to resection. In contrast with treatment of other hepatic malignancies, radiofrequency ablation is not equivalent to resection for colorectal liver metastases and should not be used as an alternative but limited to inoperable patients. Although overall survival rate after resection can be up to 71% at 5 years, the majority of patients develop recurrence. Preoperative chemotherapy contributes to decrease the risk of recurrence after resection of colorectal liver metastases. In patients with advanced solitary colorectal liver metastasis initially non suitable for resection, chemotherapy and portal vein embolization contribute to increase the number of surgical candidates whereas radiofrequency is rarely an option.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

Substances

LinkOut - more resources

Feedback